COMPASS Pathways - CMPS Net Assets per Single Share

Graphic logo of COMPASS Pathways plc (CMPS)

COMPASS Pathways plc (CMPS) develops psilocybin-based therapies, where growth is constrained by the requirement for physicians to provide in-person patient support. This daily price chart confirms the asset's current valuation at 0.62. The appeal of the company's mission helps the firm recruit leading experts, while its environmental policy is limited to standard chemical disposal and energy consumption control within laboratories.

COMPASS Pathways PLC (CMPS): Share Book Value from 07/04/2022 to 10/26/2026

compasspathways.com - analytical breakdowns and key metrics (CMPS)

- price and consensus price forecast:
Price Chart Compass Pathways|CMPS - Forecast Levels Chart
- market capitalization data:
Market Value COMPASS Pathways plc|CMPS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share COMPASS Pathways|CMPS - Net Asset Value|Market Capitalization to Book Value Ratio compasspathways.com|CMPS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital COMPASS Pathways plc|CMPS - Long-Term Debt to Capital|Short-Term Debt to Equity COMPASS Pathways|CMPS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio COMPASS Pathways plc
Fundamental company valuation:Compass Pathways - CMPS
Manufactured products of COMPASS Pathways

COMPASS Pathways plc (CMPS) is investing in the development of synthetic psilocybin for the treatment of treatment-resistant depression, which requires significant capital expenditures in scientific research. The equity-to-share ratio, reflecting the actual value of net assets, allows for the monitoring of the issuer's financial stability via GURU.Markets tools, assessing the current book value per share as the company's defensive buffer against market risks.

Competitors of COMPASS Pathways plc (CMPS)

Net Assets per Single Share Alkermes Inc.|AVDL: Share Book Value|Atai Life Sciences N.V. - Net Assets per Single Share|GHRS (ghres.com) - Net Assets per Share|Net Assets per Single Share MindMed MNMD|Share Book Value LB Pharmaceuticals, Inc.|Bright Minds Biosciences Inc (DRUG) - Book Value per Share|Accounting Value of a Share Vanda (VNDA)|Book Value per Share CYBN (Cybin)|altoneuroscience.com - Book Value per Share|Net Assets per Single Share NRx Pharmaceuticals, Inc. (NRXP)|CING: Accounting Value of a Share|SILO (Silo Pharma, Inc.) - Net Assets per Single Share|China Pharma Holdings, Inc. (CPHI) - Accounting Value per Share|CMND (Clearmind Medicine) - Book Value per Share|Book Value per Share pacificbayminerals.com (PBM)|SciSparc (SPRC) - Accounting Value per Share|Accounting Value of a Share SEEL (Seelos Therapeutics Inc.)|Virpax Pharmaceuticals, Inc. (VRPX) - Net Assets per Single Share|Karuna Pharma - Share Book Value